SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2030Myriad Genetics Stock Hits New High Monday October 1, 3:24 pm ET Myriad Geneticssim1-10/1/2007
2029if anyone wants the Citi report, pm your email and i will forward. gambatte. mopgcw-9/28/2007
2028Citi Starts Myriad at 'Hold,' Expecting Negative Trial Results for Alzhesim1-9/18/2007
2027A Genetic Test That Very Few Need, Marketed to the Masses [NYT] By ANDREW POLLADoc Bones-9/11/2007
2026MYGN: Myriad Genetics: Flurizan trials will not see setbacks en 2007-08-30 14:08mopgcw-9/6/2007
2025Nice. <i>The new genome, Dr. Venter’s team reports, makes clear that the tom pope-9/3/2007
2024Prolexys Pharmaceuticals Initiates Phase 1 Study Wednesday August 29, 7:00 am ETscaram(o)uche-8/29/2007
2023i dont agree with the tie-in to nrmx, for the reasons you pointed out, and i do mopgcw-8/28/2007
2022Notable Calls profiles Piper Jaffrey's call saying that MYGN could be under tuck-8/27/2007
2021Myriad, Meet Oprah By Brian Lawler August 23, 2007 0 Recommendations As earningmopgcw-8/23/2007
2020Molecular diagnostics revenue, annualizing last quarter forward, running at bettscaram(o)uche-8/21/2007
2019Connection? Myriad Genetics has a potential blockbuster drug in the works thattom pope-8/7/2007
2018[graphic]tom pope-8/7/2007
2017A drug to slow Alzheimer's cruel march Myriad Genetics has a potential blocsim1-8/7/2007
2016five year high........ finance.yahoo.comscaram(o)uche-8/7/2007
2015BMC Neurosci. 2007 Jul 24;8(1):54 [Epub ahead of print] Chronic administration scaram(o)uche-7/31/2007
2014Myriad Genetics Launches New Molecular Diagnostic Test TheraGuide 5-FU May Helpidos-7/26/2007
2013Myriad Genetics Holder Citadel Raises Stake to 5.5% (Update3) 2007-07-06 16:26 (mopgcw-7/20/2007
2012Not really new, however. Older data said the same thing.... once you've scaram(o)uche-7/12/2007
2011Interesting. Thx.kenhott-7/12/2007
2010NEJM Volume 357:115-123 July 12, 2007 Clinical Outcomes of Breast Cancer in Cscaram(o)uche-7/11/2007
2009<i>Prolexys Uses Pull-Down Assay to Identify Indications for Anti-Cancer Sscaram(o)uche-7/6/2007
2008Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anscaram(o)uche-6/21/2007
2007New Research Demonstrates Broad Efficacy Of Azixa(TM) (MPC-6827) Against Multiplsim1-6/20/2007
2006Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials Tuesday June 19,sim1-6/19/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News